Skip to main content

Together we are beating cancer

Donate now

Research and trials

Showing 12 out of 1701 results
An image of a scientist working in the lab, with her back turned to the camera.

Radiotherapy doesn't have to be given from outside the body. Radioactive implants and drinks stay close to tumours to minimise side effects. Radiotherapy doesn't have to be given from outside the body. Radioactive implants and drinks stay close to tumours to minimise side effects.

by Emma Maiden | Analysis | 24 October 2017

24 October 2017

This entry is part 6 of 11 in the series Radiotherapy

A new approach to targeting key cancer-linked proteins, thought to be ‘undruggable’, has been discovered through an alliance between industry and academia A new approach to targeting key cancer-linked proteins, thought to be ‘undruggable’, has been discovered through an alliance between industry and academia

by Cancer Research UK | News | 18 October 2017

18 October 2017

Breast cancer screening

The results of a breast cancer trial we helped fund allowed surgeons to move away from ‘radical’ mastectomies towards kinder, less invasive surgeries. The results of a breast cancer trial we helped fund allowed surgeons to move away from ‘radical’ mastectomies towards kinder, less invasive surgeries.

by Fiona Conway-Jones | Analysis | 2 October 2017

2 October 2017

This entry is part 28 of 30 in the series Our milestones
  • Health & Medicine
  • Personal Stories

Taking part in clinical trials – Tommy’s story

In 2012, Tommy Brennan was diagnosed with bladder cancer. Here, he shares his story and his experience of joining a Cancer Research UK-funded clinical trial. In 2012, Tommy Brennan was diagnosed with bladder cancer. Here, he shares his story and his experience of joining a Cancer Research UK-funded clinical trial.

by Cancer Research UK | Analysis | 26 September 2017

26 September 2017

A greater understanding of the biology of mesothelioma has led to new clinical trials testing immunotherapies and targeted drugs against the disease. A greater understanding of the biology of mesothelioma has led to new clinical trials testing immunotherapies and targeted drugs against the disease.

by Justine Alford | Analysis | 26 September 2017

26 September 2017